Tabelecleucel

Ebvallo 5×10E7 cellen/ml, dispersie voor injectie

Dispersie voor injectieNetherlandsAuthorisedAuthorised 16 Dec 2022

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

EbvalloEuropean UnionAuthorised

Ebvallo 2,8 × 10E7 - 7,3 × 10E7 Células /ML Dispersion InyectableSpain · 5 x 10E7 células/ml · dispersión inyectable · Pierre Fabre MedicamentSame brand
EbvalloEuropean Union · Pierre Fabre MedicamentSame brand
EbvalloCroatiaSame brand
EbvalloItaly · Dispersione per preparazione iniettabile · Pierre Fabre MedicamentSame brand

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Tabelecleucel

Ebvallo 5×10E7 cellen/ml, dispersie voor injectie

Dispersie voor injectieNetherlandsAuthorisedAuthorised 16 Dec 2022

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

EbvalloEuropean UnionAuthorised

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Summary of product characteristicsCBG-MEB

Register entryCBG-MEB

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

College ter Beoordeling van Geneesmiddelen

College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.

Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim · Added 8 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Tabelecleucel
Dosage form: Dispersie voor injectie
Route: Intraveneus gebruik
Register: Netherlands (CBG-MEB)
Status: Authorised
Status in the register: Ingeschreven
Authorised: 16 Dec 2022
Registration: EU/1/22/1700
Marketing authorisation holder: Pierre Fabre Medicament
ATC code: L01XL09
Group: Antineoplastic and immunomodulating agents
Procedure: EU centralised
Supply: Uitsluitend recept
EMA product number: EMEA/H/C/004577
EU number: EU/1/22/1700